LH R H -
histamine from mast cells [1] , These features in clude a group of hydrophobic amino acids at the N-terminal and strongly basic residues in positions 6 and 8 , notably D -Arg6,Arg8. A prime example o f this class o f antagonists is [N -A c -D -2 -N a l',D -4 F -P h e 2 ,D -T rp 3, D -A rg 6] -LH R H [2] , It was recently shown that some antag onists bind to rat peritoneal mast cells and mem brane preparations and that the binding was relat ed to the release of histamine [3] .
We recently developed Antide (analog 1, Table III ) which lacked strongly basic residues and which showed high potency and negligible histamine re lease [4] , F urther evaluation of the anaphylactoid activity o f Antide concluded that Antide "repre sents a new generation of LH R H antagonists with an improved safety m argin" [5] . Verlag der Zeitschrift für Naturforschung, D-7400 Tübingen 0932-0776/91/0900-1231/S01.00/0
The mechanism(s) for this long-term action of Antide seems to include binding to serum proteins for a peripheral depot effect, and structural stabili ty to enzymic cleavage. Binding to proteins result ed from studies using a radioreceptor assay [9] , If a depot effect, regardless o f mechanism, is at least partially responsible for the long duration of action of Antide, the relatively poor water solubili ty at physiological pH may actually be an advan tage. There are, however, reports that low water solubility has caused problems [1 0 , 1 1 ].
It was thus considered of importance to modify Antide and some potent analogs [4, 12] in order to increase their water solubility and to study how this would effect the biological activities of the re sulting analogs.
We describe the synthesis and bioassays of some new analogs with improved water solubility.
Experimental

M aterials
BOC-Ser(O Bzl), B O C -P ro , B O C -L eu and B O C -D -A la were obtained from Peninsula Laboratories, Belmont, CA. Abu was obtained from Sigma Chemical Company, St. Louis, MO and it was converted to the BOC-derivative using standard procedures [13] . All synthesized amino acids and intermediates were characterized by N M R and were homogen ous on TLC.
The benzhydrylamine hydrochloride resin was purchased from Beckman Bioproducts, Palo Alto, CA. The dicyclohexylcarbodiimide was from Aidrich and was distilled in vacuo before use. The dichlorom ethane was distilled from sodium car bonate. All other solvents and reagents were reagent grade.
Synthesis
The peptides were synthesized by the solidphase method using a Beckman autom ated 990 peptide synthesizer. The protocol used was essen tially as described [19] , The peptide was cleaved from the resin with concom itant removal of all protecting groups by treatm ent with doubly dis tilled H F( 1) at 0 °C for 1 h in the presence of about 10% anisole of/?-cresol. The H F was then evapor ated, in vacuo, first by a water aspirator and then by pum p vacuum overnight. The residue was then extracted 2 -3 times with ether in order to remove non-peptidic material. The crude peptide was sub sequently extracted with aqueous acetic acid and the extract was lyophilized.
Purification and Characterization
Purification was achieved by chrom atography on S i0 2 (EM , 230-400 mesh) with the solvent sys tem «-butanol:acetic acid:w ater 4:1:2 or 4:1:5 (upper phase) followed by gel filtration on Sephadex G 25 with 6 % aqueous acetic acid as the eluant. An alternative purification method was gel filtration as above followed by chrom atography on Sephadex LH 20 with the solvent system w ater:«-butanol:acetic acid:m ethanol 90:10:10:8.
The purity was checked by TLC, amino acid analysis and HPLC.
The peptides gave single spots on TLC (EM, 0.25 mm SiO^) in four different solvent systems (Table I) .
Am ino acid analyses were carried out on a Beck man 118 CL amino acid analyzer after hydrolysis in constant boiling HC1 for 24 h using standard procedures [19] . The unnatural amino acids were qualitatively determined with the exception of 3-Pal which was quantified. The data are in Table II . The purity was further checked by HPLC using a Waters instrum ent with a 660 solvent pro-grammer and a Vydac C 18 column. The flow rate was 1.5 ml/min and the absorbance was recorded at 210 nm. Different gradients o f increasing con centration of acetonitrile in 0.01 M K H 2P 0 4, ad justed to pH 3 with H 3 P O 4 , were employed. All peptides were estimated to be 9 7 -9 9 % pure in this system (data not shown). 
Biological assays
AOA in rats was determined as reported [20] . The wheal area/10 jug of analog was calculated as described [4] , The histamine release was assayed in rat mast cells as reported [21, 22] , The E D 50 value reported is the concentration in //g/ml that releases 50% of total releasable histamine. The biological data are in Table III .
Results and Discussion
The strategy for design was to make single-residue changes in analogs with good potency in order to increase water solubility. Positions 1, 5 and 6 were chosen for these changes. Position 1 has D -2 -N a l in five analogs selected for this study. D -2-Nal has been a dom inant substituent in posi tion 1 for some time [23] , and its very lipophilic character made it a suitable candidate for substitu tion. As a replacement, we chose D -3 -Q a l which isosteric with D -2 -N al but much more hydrophilic. In one peptide, D -3 -P al was placed in position 1.
Positions 5 and 6 were selected because, in Antide and its congeners, they are occupied by a new class of amino acids, acylated lysines and aminocyclohexylalanines. Since in earlier analogs, these positions were often occupied by basic, hydrophil ic residues [23] , the relatively poor water solubility of Antide and its analogs may be, at least partly, attributed to these residues. In positions 5 and 6 , the more hydrophilic am i no acids, D -and L -3 -P a l, PzAla, (DSer)Lys and D -(A cD Ser)L ys were used.
Substitutions in position 1
D -2 -N a l has been replaced by D -3 -Q al in four peptides. In Antide (analog 1) the AOA decreased from 36 to 0% at 0.5 /ig (analog 2). The wheal area decreased considerably, from 132.7 to 8 8 . 8 mm [2] , When D -3 -Q a l was incorporated into analog 10 [12] the AOA potency remained high, 55% at 0.25 /.ig and 17% at 0.125 /.ig. Even more interest ing, however, may be the observation that the ED 50 for histamine release increased from 49 to 171 f.igjm\ and the wheal area is small, only 82.9 mm [2] , These data support the concept that a very lipophilic N-terminal prom otes histamine re lease. Analog 11 may have a high margin of safety.
Analog 19 with Abu in position 7 [12] and analog with AOPP [15, 16] in positions 6 -7 have also been substituted with D -3 -Q al in position 1. The resulting analogs 2 0 and 2 2 were both inactive at 0.25 jug as compared to AOA values of 36 and 44% for the parent compounds.
In summary, four peptides have been substitut ed with D -3 -Q al in position 1. One retained its potency, and the other three showed no activity at the level tested. The analog that retained its potency had the largest lipophilicity o f the group, featuring c-PzACAla5,D -P ic L y s6,Leu7. Antide has NicLys5,D -N icL y s6,Leu7. Analog 19 has PicLys5,D -P icL y s6,A bu7 and analog 21 has PicLys5, AOPP6-7 which lacks the long acylated side chain normally present in position 6 . These three latter peptides lost their AOA upon replacement of D -2 -N a l by D -3 -Q al. Consequently, it seems that in order for the hydrophilic quinolylalanine to be effective, its hydrophilicity should be balanced by increased lipophilicity elsewhere in the mole cule.
Analog 12 has the considerably smaller D -3-P al instead of D -2 -N al in position 1. The AOA de creased to 20% at 0.25 //g, but taking into account the structural difference between D -2 -N al and D -3-Pal, the value of 20% is noteworthy.
Substitutions in position 5
Analog 6 has PicLys5 in the parent analog (5) [4] replaced by (DSer)Lys. This change caused a large decrease in potency, and the AOA was 13 and 0% at 0.5 and 0.25 jig, respectively, as compared to 100 and 40% for analog 5. The ED 50 for histamine release was decreased fourfold, from 93 to 22 jug/ ml. This result is not surprising since (DSer)Lys contains a basic am ino group and PicLys does not.
The very potent analog 16 [12] , with the c-D -P zA C A la moiety in position 6 has been m od ified in position 5 with 3-Pal and PzAla (analogs 17 and 18). Both substitution reduced the potency to ca. one-half or from 73% to 33 and 44%, re spectively, at 0.25 jig. The analogs did, however, retain considerable activity. The ED 50 value was reduced from 28 to 16 for the 3-Pal5 analog, but the corresponding value for the analog with the much less basic [24] PzAla remained unchanged.
Substitutions in position 6
D -PzAla has been incorporated in position 6 in Antide (analog 1), analog 5 and analog 10. In the case o f Antide, a considerable increase in potency was noted at 0.5 jig, 8 8 vs. 36% (analog 3). At 0.25 jug, like Antide, analog 3 was however inac tive. Its wheal area was notably small, 83 mm2.
In analog 5, the same substitution caused a sub stantial decrease in potency, 9 vs. 40% at 0.25 jug (analog 9), but analog 13 was equipotent with its parent com pound 10, 63 vs. 67% at the same dose level. It is evident, as has been often noted, that the same am ino acid residue can cause widely different effects on AOA depending on the sequence in which it is introduced.
O f im portance is the lowering of histamine re lease by D -P z A la 6 introduction into analog 13; the ED 50 increased from 49 to 8 It seems that the (DSer)Lys moiety is effective only if very specific structural features are present in the rest of the chain [25] . The high potency of analog 7 is also remarkable in com parison with analog 6 which has (DSer)Lys in position 5 and was in active at 0.25 jug. The latter analog was designed toward reducing histamine release by moving the basic residue from position 6 to position 5 accord ing to Rivier et al. [26] , The E D 50 value for analog 6 was, however, 22 com pared to 18 for analog 7, that is they are very similar. Analog 8 has D -(A cD Ser)L ys in position 6 . This peptide was designed in order to learn if his tamine release would be affected upon acetylation of the serine amino group. This was the case. The ED 50 for 8 was 53, an increase from the value of 18 for analog 7. The wheal areas are also very similar, 97.2 vs. 103.9 mm2. Analog 8 was inactive at 0.25 jig which indicates that the basicity may be necessary in this residue for good AOA potency.
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